Traws Pharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.4M | $55.5M | $55.1M |
| FY2022 | $11.1M | $39.4M | $38.5M |
| FY2023 | $12.0M | $22.7M | $20.6M |
| FY2024 | $56.6M | $25.0M | $21.3M |
| FY2025 | $11.2M | $10.6M | $3.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.4M | $55.5M | $55.1M |
| FY2022 | $11.1M | $39.4M | $38.5M |
| FY2023 | $12.0M | $22.7M | $20.6M |
| FY2024 | $56.6M | $25.0M | $21.3M |
| FY2025 | $11.2M | $10.6M | $3.8M |